RemedyRepack Inc. FDA Record
- Latest inspection OAI · Apr 14, 2025
- 1 Class I recall
- Last warning letter 2023
RemedyRepack Inc. has 61 FDA recalls (1 Class I), 6 inspections, 0 510(k) clearances and 2 compliance actions on record. FDA has issued 2 warning letters to RemedyRepack Inc., the most recent on May 11, 2023.
- Latest recall
- D-0411-2025 · Class II · Apr 22, 2025
- Latest inspection
- Apr 14, 2025 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 61 (1 Class I) | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 6 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 2 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
RemedyRepack Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 1 | 0 | 3 | 0 |
| 2024 | 0 | 0 | 0 | 4 | 0 |
| 2023 | 0 | 0 | 1 | 17 | 0 |
| 2022 | 1 | 1 | 0 | 7 | 0 |
| 2021 | 0 | 0 | 0 | 3 | 0 |
| 2020 | 0 | 0 | 0 | 2 | 0 |
| 2019 | 0 | 0 | 0 | 5 | 1 |
| 2018 | 1 | 0 | 0 | 9 | 0 |
| 2017 | 0 | 0 | 0 | 2 | 0 |
Reviewing RemedyRepack Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check RemedyRepack Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
RemedyRepack Inc. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| May 11, 2023 · Letter on fda.gov | CGMP/Finished Pharmaceuticals/Adulterated | Division of Pharmaceutical Quality Operations I | |
| Mar 31, 2015 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0411-2025 | Class II | Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack… | Apr 22, 2025 |
| D-0378-2025 | Class II | Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack… | Mar 24, 2025 |
| D-0217-2025 | Class II | Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by… | Jan 24, 2025 |
| D-0165-2025 | Class II | Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30… | Dec 2, 2024 |
| D-0611-2024 | Class II | Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx only… | Jun 26, 2024 |
| D-0549-2024 | Class II | Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc… | May 31, 2024 |
| D-0489-2024 | Class II | TraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count… | May 2, 2024 |
| D-0577-2023 | Class II | Ketotifen Fumarate 0.025 %, Antihistamine eye drops, 5mL bottle, MFG: Akorn, Lake Forrest IL 60045… | May 1, 2023 |
| D-0578-2023 | Class II | Pyrazinamide, 500 mg Tablet, packaged in a) 29 x 30-count card, NDC # 70518-2534-01; b) 1 x 100 UD… | May 1, 2023 |
| D-0576-2023 | Class II | LORazepam Injection, 2mg / mL Single Dose vial 1ml vial, Rx Only, MFG Akorn Lake Forest IL 60045… | May 1, 2023 |
| D-0493-2023 | Class II | Glimepiride 2 mg tablets, packaged in a) 30-count bottles (NDC 70518-0405-03), b) 90-count bottles… | Mar 20, 2023 |
| D-0503-2023 | Class II | Simvastatin 40 mg tablets, packaged in a) 30-count bottles (NDC 70518-0060-01) and b) 90-count… | Mar 20, 2023 |
| D-0496-2023 | Class II | Simvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-0064-01) and b) 90-count… | Mar 20, 2023 |
| D-0492-2023 | Class II | Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC… | Mar 20, 2023 |
| D-0490-2023 | Class II | Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA… | Mar 20, 2023 |
| D-0495-2023 | Class II | Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA… | Mar 20, 2023 |
| D-0500-2023 | Class II | Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA… | Mar 20, 2023 |
| D-0491-2023 | Class II | Atorvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-1946-00) and b) 90-count… | Mar 20, 2023 |
| D-0494-2023 | Class II | Ropinirole 0.5 mg tablets, packaged in 90-count bottles, Rx only, Repackaged by: RemedyRepack Inc… | Mar 20, 2023 |
| D-0499-2023 | Class II | Ropinirole 2mg tablets, packaged in 180-count bottles, Rx only, Repackaged by: RemedyRepack Inc… | Mar 20, 2023 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Apr 14, 2025 | Indiana, PA | Drugs | Official Action Indicated (OAI) | 3005841768 |
| Nov 10, 2022 | Indiana, PA | Drugs | Official Action Indicated (OAI) | 3005841768 |
| Mar 30, 2018 | Indiana, PA | Drugs | Voluntary Action Indicated (VAI) | 3005841768 |
| Nov 23, 2015 | Indiana, PA | Drugs | Voluntary Action Indicated (VAI) | 3005841768 |
| May 16, 2011 | Indiana, PA | Drugs | Voluntary Action Indicated (VAI) | 3005841768 |
| May 28, 2009 | Indiana, PA | Drugs | Voluntary Action Indicated (VAI) | 3005841768 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 2 compliance actions under RemedyRepack Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3005841768 | Indiana, PA | 6 | Apr 14, 2025 |
RemedyRepack Inc. and the FDA: common questions
Has RemedyRepack Inc. received an FDA warning letter?
Yes. FDA has issued 2 warning letters to RemedyRepack Inc.. The most recent is dated May 11, 2023, with the subject "CGMP/Finished Pharmaceuticals/Adulterated".
Has RemedyRepack Inc. received an FDA Form 483?
FDA has not published a Form 483 for "RemedyRepack Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect RemedyRepack Inc.?
The most recent FDA inspection on file ended Apr 14, 2025 at Indiana, PA and was classified OAI. FDA has 6 inspections of RemedyRepack Inc. on file, 2 of them classified OAI (official action indicated).
Has RemedyRepack Inc. had an FDA recall?
Yes. RemedyRepack Inc. has 61 FDA recalls on record, 1 of them Class I, the most serious class. The most recent started Apr 22, 2025.
Need more than this page shows? Ask about RemedyRepack Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.